BART GATZ: Open Payments
NPI 1801819206 · GREENACRES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$626 in 29 payments from 7 companies in 2025. Trend: 2023 $1,003 · 2024 $807 · 2025 $626
Food & beverage: $626
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 6 | $233 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $183 |
| ABBVIE INC. | 4 | $83 |
| Collegium Pharmaceutical, Inc. | 4 | $71 |
| PROTEGA PHARMACEUTIALS INC | 1 | $23 |
| Forte Bio-Pharma LLC | 1 | $18 |
| BIOTRONIK NRO, Inc. | 1 | $16 |
Products named: ETERNA, RELISTOR, QULIPTA, XTAMPZA, Belbuca, ROXYBOND, PROLATE, BOTOX.
Industry payments across FL — which companies pay providers there.
